Perfect Timiming.., page-59

I am an hcv sufferer, and was a holder until yesterday. I don't like to admit it but I agree with red cordial, there are other drugs about to enter the market that can be used without interferon and ribarvirran, drugs that I have personally taken and can vouch are very nasty. Unfortunately biotrons timing to launch their drug has been later than their competitors, which is no fault of their own. The company Has acted very professionally and always in the interests of their shareholders, but as we all know without the aid of the big pharmacutical players, a small cap company goes down very quickly. It is with ambiguity that I wish all holders well as I have sold my stock. Perhaps I will come back on board if things look more favourable.